CSL Limited

80 articles about CSL Limited

• US FDA Approves Sanofi-Aventis (France), CSL Limited, MedImmune (JOBS), Novartis AG (JOBS) H1N1 Vaccine, Says Enough for Everyone

  9/16/2009

• CSL Limited Release: Trial Of Novel H1N1 ‘Swine’ Flu Candidate Vaccine To Take Place In Adelaide

  7/1/2009

• CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement

  6/8/2009

• CSL Limited Says U.S. Regulator May Block Talecris Biotherapeutics Deal

  5/26/2009

• Xencor And CSL Limited Establish Antibody Optimization Collaboration

  2/23/2009

• Opsona Therapeutics Ltd., CSL Limited Form Vaccine Adjuvant R&D Collaboration Targeting Infectious Diseases And Oncology

  2/23/2009

• DSM Biologics And Crucell N.V. Announce PER.C6(R) License Agreement with CSL Limited

  12/18/2008

• WEHI Spin-Out MuriGen Therapeutics Restructures G-CSF Antagonist Program With CSL

  10/27/2008

• BioWa Licenses POTELLIGENT(R) Technology to CSL Limited

  10/9/2008

• Australia's CSL Limited to Buy Talecris Biotherapeutics for $3.1 Billion

  8/13/2008

• FDA Approves 2008-2009 Season's Flu Vaccines: CSL Limited, Afluria. GlaxoSmithKline Biologicals, Fluarix. ID Biomedical Corporation of Quebec, FluLaval. MedImmune Vaccines, FluMist. Novartis Vaccines & Diagnostics, Inc., Fluvirin. Sanofi Pasteur, Fluzone.

  8/6/2008

• Arana Therapeutics Completes Second Project with CSL Limited

  6/4/2008

• CSL Limited Marks 40 Years in the Influenza Vaccine Market

  5/13/2008

• Arana Therapeutics Achieves Milestone in Collaboration with CSL Limited

  2/4/2008

• Celltrion, Inc. and CSL Limited Announce Collaboration to Develop and Manufacture Monoclonal Antibody

  1/10/2008

• CSL Limited Preclinical Studies Show Promise for Novel Antibody Therapy to Treat Acute Myeloid Leukemia

  12/10/2007

• Arana Therapeutics Completes Project With CSL Limited

  11/29/2007

• MedImmune, Inc. Licenses Reverse Genetics Technology To CSL Limited For Use In Influenza Vaccine Production

  12/20/2006

• EvoGenix Limited Announces Antibody Collaboration With CSL Limited

  6/1/2006

• CSL Limited To Apply For License To Market Influenza Vaccine In The U.S.

  2/7/2006